{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T15:05:29Z","timestamp":1790175929319,"version":"4.1.0"},"reference-count":39,"publisher":"American Medical Association (AMA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2020.6742","type":"journal-article","created":{"date-parts":[[2020,5,29]],"date-time":"2020-05-29T15:32:59Z","timestamp":1590766379000},"page":"e206742","source":"Crossref","is-referenced-by-count":37,"title":["Assessment of Patient and Caregiver Attitudes and Approaches to Decision-Making Regarding Bone Marrow Transplant for Sickle Cell Disease"],"prefix":"10.1001","volume":"3","author":[{"given":"Nitya","family":"Bakshi","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Division of Hematology-Oncology-BMT, Emory University School of Medicine, Atlanta, Georgia"},{"name":"Aflac Cancer and Blood Disorders Center of Children\u2019s Healthcare of Atlanta, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deeksha","family":"Katoch","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Hematology-Oncology-BMT, Emory University School of Medicine, Atlanta, Georgia"},{"name":"Aflac Cancer and Blood Disorders Center of Children\u2019s Healthcare of Atlanta, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia B.","family":"Sinha","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Hematology-Oncology-BMT, Emory University School of Medicine, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Ross","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Hematology-Oncology-BMT, Emory University School of Medicine, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maa-Ohui","family":"Quarmyne","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Hematology-Oncology-BMT, Emory University School of Medicine, Atlanta, Georgia"},{"name":"Aflac Cancer and Blood Disorders Center of Children\u2019s Healthcare of Atlanta, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Loewenstein","sequence":"additional","affiliation":[{"name":"Department of Social and Decision Sciences, Carnegie Mellon University, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lakshmanan","family":"Krishnamurti","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Hematology-Oncology-BMT, Emory University School of Medicine, Atlanta, Georgia"},{"name":"Aflac Cancer and Blood Disorders Center of Children\u2019s Healthcare of Atlanta, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2020,5,29]]},"reference":[{"issue":"4","key":"zoi200299r1","doi-asserted-by":"publisher","first-page":"S512","DOI":"10.1016\/j.amepre.2009.12.022","article-title":"Population estimates of sickle cell disease in the U.S.","volume":"38","author":"Hassell","year":"2010","journal-title":"Am J Prev Med"},{"key":"zoi200299r2","doi-asserted-by":"publisher","first-page":"18010","DOI":"10.1038\/nrdp.2018.10","article-title":"Sickle cell disease.","volume":"4","author":"Kato","year":"2018","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"zoi200299r3","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/pbc.v59.2","article-title":"Health-related quality of life in sickle cell disease: past, present, and future.","volume":"59","author":"Panepinto","year":"2012","journal-title":"Pediatr Blood Cancer"},{"issue":"23","key":"zoi200299r4","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1056\/NEJM199406093302303","article-title":"Mortality in sickle cell disease. Life expectancy and risk factors for early death.","volume":"330","author":"Platt","year":"1994","journal-title":"N Engl J Med"},{"issue":"6","key":"zoi200299r5","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1182\/blood-2018-10-880575","article-title":"Decreased median survival of adults with sickle cell disease after adjusting for left truncation bias: a pooled analysis.","volume":"133","author":"DeBaun","year":"2019","journal-title":"Blood"},{"issue":"11","key":"zoi200299r6","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1182\/blood-2016-10-745711","article-title":"Sickle cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation.","volume":"129","author":"Gluckman","year":"2017","journal-title":"Blood"},{"issue":"2","key":"zoi200299r7","first-page":"100","article-title":"Barriers to bone marrow transplantation for sickle cell anemia.","volume":"2","author":"Walters","year":"1996","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"zoi200299r8","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.blre.2014.08.001","article-title":"Blood and marrow transplantation for sickle cell disease: is less more?","volume":"28","author":"Bola\u00f1os-Meade","year":"2014","journal-title":"Blood Rev"},{"issue":"4","key":"zoi200299r9","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1097\/MPH.0b013e31828d5e6a","article-title":"Barriers to hematopoietic cell transplantation clinical trial participation of African American and black youth with sickle cell disease and their parents.","volume":"35","author":"Omondi","year":"2013","journal-title":"J Pediatr Hematol Oncol"},{"issue":"7","key":"zoi200299r10","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1002\/pbc.v62.7","article-title":"Current attitudes of parents and patients toward hematopoietic stem cell transplantation for sickle cell anemia.","volume":"62","author":"Meier","year":"2015","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"zoi200299r11","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/MPH.0000000000001433","article-title":"Parent and guardian knowledge of hematopoietic cell transplantation as a treatment option for sickle cell disease.","volume":"41","author":"Stallings","year":"2019","journal-title":"J Pediatr Hematol Oncol"},{"issue":"7","key":"zoi200299r12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0178413","article-title":"Proponent or collaborative: Physician perspectives and approaches to disease modifying therapies in sickle cell disease.","volume":"12","author":"Bakshi","year":"2017","journal-title":"PLoS One"},{"issue":"4","key":"zoi200299r13","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1002\/pbc.23304","article-title":"Bone marrow transplant options and preferences in a sickle cell anemia cohort on chronic transfusions.","volume":"58","author":"Hansbury","year":"2012","journal-title":"Pediatr Blood Cancer"},{"issue":"11","key":"zoi200299r14","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1016\/j.bbmt.2012.05.013","article-title":"Stem cell transplant for children with sickle cell anemia: parent and patient interest.","volume":"18","author":"Roth","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"zoi200299r15","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/sj.bmt.1703208","article-title":"Allogeneic stem cell transplantation for sickle cell disease. A study of patients\u2019 decisions.","volume":"28","author":"van Besien","year":"2001","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"zoi200299r16","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/sj.bmt.1705622","article-title":"A survey on patient perception of reduced-intensity transplantation in adults with sickle cell disease.","volume":"39","author":"Chakrabarti","year":"2007","journal-title":"Bone Marrow Transplant"},{"issue":"19","key":"zoi200299r17","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1056\/NEJM199111073251905","article-title":"Bone marrow transplantation for sickle cell disease. A study of parents\u2019 decisions.","volume":"325","author":"Kodish","year":"1991","journal-title":"N Engl J Med"},{"issue":"12","key":"zoi200299r19","doi-asserted-by":"crossref","DOI":"10.2196\/14462","article-title":"Comparative effectiveness of a web-based patient decision aid for therapeutic options for sickle cell disease: randomized controlled trial.","volume":"21","author":"Krishnamurti","year":"2019","journal-title":"J Med internet Res"},{"issue":"9","key":"zoi200299r20","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1097\/ACM.0000000000000388","article-title":"Standards for reporting qualitative research: a synthesis of recommendations.","volume":"89","author":"O\u2019Brien","year":"2014","journal-title":"Acad Med"},{"issue":"1","key":"zoi200299r21","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/j.1365-2648.2007.04569.x","article-title":"The qualitative content analysis process.","volume":"62","author":"Elo","year":"2008","journal-title":"J Adv Nurs"},{"issue":"12","key":"zoi200299r22","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1002\/pbc.v60.12","article-title":"An educational symposium for patients with sickle cell disease and their families: results from surveys of knowledge and factors influencing decisions about hematopoietic stem cell transplant.","volume":"60","author":"Thompson","year":"2013","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"zoi200299r23","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/j.bbmt.2017.11.018","article-title":"Experiences and decision making in hematopoietic stem cell transplant in sickle cell disease: patients\u2019 and caregivers\u2019 perspectives.","volume":"24","author":"Khemani","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"zoi200299r24","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1016\/S0749-5978(02)00021-3","article-title":"Framing decisions: hypothetical and real.","volume":"89","author":"Kuhberger","year":"2002","journal-title":"Organ Behav Hum"},{"issue":"2","key":"zoi200299r25","doi-asserted-by":"publisher","first-page":"263","DOI":"10.2307\/1914185","article-title":"Prospect theory: analysis of decision under risk.","volume":"47","author":"Kahneman","year":"1979","journal-title":"Econometrica"},{"issue":"3","key":"zoi200299r26","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1177\/0272989X9901900313","article-title":"Health values and prospect theory.","volume":"19","author":"Treadwell","year":"1999","journal-title":"Med Decis Making"},{"issue":"5","key":"zoi200299r27","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1097\/00005650-199905000-00007","article-title":"Associations between health status and utilities implications for policy.","volume":"37","author":"Lenert","year":"1999","journal-title":"Med Care"},{"issue":"8","key":"zoi200299r28","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1016\/j.socscimed.2007.06.012","article-title":"Current health and preferences for life-prolonging treatments: an application of prospect theory to end-of-life decision making.","volume":"65","author":"Winter","year":"2007","journal-title":"Soc Sci Med"},{"issue":"6","key":"zoi200299r29","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1001\/jama.2013.285245","article-title":"Understanding choice: why physicians should learn prospect theory.","volume":"311","author":"Verma","year":"2014","journal-title":"JAMA"},{"issue":"6","key":"zoi200299r30","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1023\/A:1025119931010","article-title":"Whose quality of life? A commentary exploring discrepancies between health state evaluations of patients and the general public.","volume":"12","author":"Ubel","year":"2003","journal-title":"Qual Life Res"},{"issue":"11","key":"zoi200299r31","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1016\/S0277-9536(99)00045-3","article-title":"Integrating response shift into health-related quality of life research: a theoretical model.","volume":"48","author":"Sprangers","year":"1999","journal-title":"Soc Sci Med"},{"issue":"3","key":"zoi200299r32","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1023\/A:1023211129926","article-title":"Hi! How are you? Response shift, implicit theories and differing epistemologies.","volume":"12","author":"Norman","year":"2003","journal-title":"Qual Life Res"},{"issue":"10","key":"zoi200299r33","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1007\/s11606-012-2077-6","article-title":"Shared decision making: a model for clinical practice.","volume":"27","author":"Elwyn","year":"2012","journal-title":"J Gen Intern Med"},{"issue":"1","key":"zoi200299r34","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1001\/jama.2014.7192","article-title":"Nonmyeloablative HLA-matched sibling allogeneic hematopoietic stem cell transplantation for severe sickle cell phenotype.","volume":"312","author":"Hsieh","year":"2014","journal-title":"JAMA"},{"issue":"6","key":"zoi200299r35","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1016\/j.bbmt.2018.11.027","article-title":"Haploidentical bone marrow transplantation with post-transplantation cyclophosphamide plus thiotepa improves donor engraftment in patients with sickle cell anemia: results of an international learning collaborative.","volume":"25","author":"de la Fuente","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"zoi200299r36","first-page":"128","article-title":"Interim results from a phase 1\/2 clinical study of lentiglobin gene therapy for severe sickle cell disease.","volume":"130","author":"Kanter","year":"2017","journal-title":"Blood"},{"issue":"3","key":"zoi200299r37","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1056\/NEJMoa1715971","article-title":"A phase 3 trial of l-Glutamine in sickle cell disease.","volume":"379","author":"Niihara","year":"2018","journal-title":"N Engl J Med"},{"issue":"5","key":"zoi200299r38","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1056\/NEJMoa1611770","article-title":"Crizanlizumab for the prevention of pain crises in sickle cell disease.","volume":"376","author":"Ataga","year":"2017","journal-title":"N Engl J Med"},{"issue":"6","key":"zoi200299r39","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1056\/NEJMoa1903212","article-title":"A phase 3 randomized trial of voxelotor in sickle cell disease.","volume":"381","author":"Vichinsky","year":"2019","journal-title":"N Engl J Med"},{"key":"zoi200299r18","author":"Corbin","year":"2015"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2766547\/bakshi_2020_oi_200299.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,29]],"date-time":"2020-05-29T15:33:05Z","timestamp":1590766385000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2766547"}},"subtitle":["A Qualitative Study"],"short-title":[],"issued":{"date-parts":[[2020,5,29]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.6742","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,29]]}}}